Welcome to LookChem.com Sign In|Join Free

CAS

  • or

35905-85-2

Post Buying Request

35905-85-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35905-85-2 Usage

Chemical Properties

Light yellow Cryst

Check Digit Verification of cas no

The CAS Registry Mumber 35905-85-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,9,0 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 35905-85:
(7*3)+(6*5)+(5*9)+(4*0)+(3*5)+(2*8)+(1*5)=132
132 % 10 = 2
So 35905-85-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H4BrNO2/c7-5-4(6(9)10)2-1-3-8-5/h1-3H,(H,9,10)

35905-85-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H30239)  2-Bromonicotinic acid, 97%   

  • 35905-85-2

  • 1g

  • 306.0CNY

  • Detail
  • Alfa Aesar

  • (H30239)  2-Bromonicotinic acid, 97%   

  • 35905-85-2

  • 5g

  • 1164.0CNY

  • Detail
  • Aldrich

  • (632465)  2-Bromopyridine-3-carboxylicacid  97%

  • 35905-85-2

  • 632465-1G

  • 500.76CNY

  • Detail
  • Aldrich

  • (632465)  2-Bromopyridine-3-carboxylicacid  97%

  • 35905-85-2

  • 632465-5G

  • 1,875.51CNY

  • Detail

35905-85-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromonicotinic acid

1.2 Other means of identification

Product number -
Other names 2-BroMonicotinic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35905-85-2 SDS

35905-85-2Relevant articles and documents

1,3-Disubstituted urea derivatives: Synthesis, antimicrobial activity evaluation and in silico studies

Gündüz, Miyase G?zde,U?ur, Sümeyye Buran,Güney, Funda,?zkul, Ceren,Krishna, Vagolu Siva,Kaya, Serdal,Sriram, Dharmarajan,Do?an, ?engül Dilem

, (2020/07/31)

The development of new antimicrobial compounds is in high demand to overcome the emerging drug resistance against infectious microbial pathogens. In the present study, we carried out the extensive antimicrobial screening of disubstituted urea derivatives. In addition to the classical synthesis of urea compounds by the reaction of amines and isocyanates, we also applied a new route including bromination, oxidation and azidination reactions, respectively, to convert 2-amino-3-methylpyridine to 1,3-disubstituted urea derivatives using various amines. The evaluation of antimicrobial activities against various bacterial strains, Candida albicans as well as Mycobacterium tuberculosis resulted in the discovery of new active molecules. Among them, two compounds, which have the lowest MIC values on Pseudomonas aeruginosa, were further evaluated for their inhibition capacities of biofilm formation. In order to evaluate their potential mechanism of biofilm inhibition, these two compounds were docked into the active site of LasR, which is the transcriptional regulator of bacterial signaling mechanism known as quorum sensing. Finally, the theoretical parameters of the bioactive molecules were calculated to establish their drug-likeness properties.

PIPERIDINE COMPOUNDS AS PCSK9 INHIBITORS

-

Paragraph 0239; 0240; 0241; 0506; 0507; 0508; 0509, (2018/11/21)

One aspect of the invention relates to a series of new PCSK9 inhibitor compounds comprising piperidine ring structures, including compounds of formula (I) and/or pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating PCSK9 receptor related diseases comprising administration of one or more compounds of formula (I) or a pharmaceutically acceptable salt thereof.

Conjugate addition of 2- and 4-pyridylcuprates: An expeditious asymmetric synthesis of natural (-)-evoninic acid

Spivey, Alan C.,Shukla, Lena,Hayler, Judy F.

, p. 891 - 894 (2007/10/03)

(Chemical Equation Presented) The scope and limitations of the conjugate addition of 2- and the first 4-pyridyl Gilman homocuprates to various α,β-unsaturated Michael acceptors are delineated. The conjugate addition of the cuprate of 2-bromo-3-methylpyridine to (E)-methyl crotonate then diastereoselective enolate alkylation and lipase-mediated enantioselective ester hydrolysis have enabled an efficient four-step first asymmetric synthesis of the Celastraceae sesquiterpenoid esterifying ligand (-)-(1′S,2′S) -evoninic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35905-85-2